lobeline has been researched along with vanoxerine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crooks, PA; Deaciuc, AG; Dwoskin, LP; Grinevich, VP; Hojahmat, M; Horton, DB; Miller, DK; Norrholm, SD | 1 |
| Canoll, PD; Klein, M; Musacchio, JM | 1 |
2 other study(ies) available for lobeline and vanoxerine
| Article | Year |
|---|---|
Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters.
Topics: Animals; Esters; Ligands; Lobeline; Male; Molecular Structure; Neurons; Neurotransmitter Transport Proteins; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Stereoisomerism; Structure-Activity Relationship | 2010 |
SKF 525-A and cytochrome P-450 ligands inhibit with high affinity the binding of [3H]dextromethorphan and sigma ligands to guinea pig brain.
Topics: Animals; Binding, Competitive; Brain; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Dextromethorphan; Guinea Pigs; Kinetics; Ligands; Lobeline; Mixed Function Oxygenases; Neurotransmitter Uptake Inhibitors; Piperazines; Proadifen; Receptors, Opioid; Receptors, sigma; Sparteine | 1991 |